These 62 Big Blue Chips Are on the Move (ABEV, ALL, BLK, HRS)

It pays to stay on top of the latest profit opportunities, and today's blog post updates stock ratings in my Portfolio Grader More 

Bristol-Myers Squibb Co: The BMY Freefall Is Overdone

BMY stock has sustained a technical beatdown over the past couple of days. But Bristol-Myers Squibb is arriving at promising support. More 

3 Big Stock Charts for Friday: Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK) and Fitbit Inc (FIT)

Huge news changes the technical outlook for Merck (MRK) and Bristol-Myers (BMY) while the long-term picture favors the bulls for Fitbit (FIT). More 

Biogen Inc (BIIB) Tacks on $7B in Market Value on Buyout Talk

Biogen Inc (NASDAQ:BIIB) just made a huge move out of thin air Tuesday evening, spiking 9.5% to $330 as of this writing. Until the surge, BIIB stock was trading in the red in the sub-$300 range. So why the sudden interest in this biotech? Well, those pesky “people familiar with the matter” are at it again,... More 

How Merck & Co., Inc. Ranks As a Top Analyst Pick (MRK)

A study of analyst recommendations at the major brokerages shows that Merck is the #15 broker pick out of the 30 Dow stocks More 

10 Stellar Dow Jones Stocks to Buy for Q3

The list of Dow Jones stocks primed for more outperformance in the third quarter and beyond is topped by some surprising names. More 

7 Pharmaceuticals Stocks to Buy Now

This week, 7 Pharmaceuticals stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More